Press release
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion: A Key Factor Shaping the Future of the Visceral Pain Market in 2025
Visceral Pain Market Size
Over the past few years, significant expansion has occurred in the visceral pain market. The projection is for it to escalate from a value of $13.84 billion in 2024 to a value of $14.87 billion in 2025, a compound annual growth rate (CAGR) of 7.5%. The surge during the historical growth cycle has been driven by factors such as an older population, a surge in chronic illnesses, innovations in medical research, better healthcare facilities, and an upswing in awareness as well as diagnosis rates.
The market for visceral pain is anticipated to significantly expand in the upcoming years, predicted to hit a value of $18.71 billion in 2029, with a CAGR of 5.9%. The projected growth during this period is due to advancements in pain management technology, increasing preference for non-invasive treatments, emerging markets combined with untouched potential, tailored medical treatments, and the inclusion of digital health solutions. The period's key trends will be a move towards multimodal pain management, a heightened focus on alternative therapies, the upsurge of targeted therapies for distinct pain classifications, greater reliance on telemedicine for pain management, and the merging of artificial intelligence with pain evaluation.
What Are the Main Catalysts for Growth in the Visceral Pain Market?
The escalating need for pain relievers, also known as analgesics, is anticipated to propel the visceral pain market's expansion in the future. These analgesics function by reducing or obstructing pain receptors in the brain, thereby alleviating pain. They aid in controlling visceral pain by focusing on the nervous system and moderating pain signals from the internal organs. For example, the New England Journal of Medicine, a weekly medical journal based in the UK, reported in April 2024 that more than 53,600 clinicians had been prescribing buprenorphine by December 2023. This indicates a surge of 11,500 prescribers from December 2022. Consequently, the growing demand for analgesics is steering the growth of the visceral pain market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp
Which Businesses Are at the Forefront of Visceral Pain Market Development?
Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.
What Are the Latest Innovations in the Visceral Pain Market?
Noteworthy companies within the visceral pain market are progressing with the invention of unique products like NHE3 Inhibitor, aiming to offer trustworthy services to their consumers. NHE3 inhibitors fall under the category of drugs that function by impeding the Sodium-Proton-Exchanger subtype 3 (NHE3) within the digestive system. For example, in April 2022, a biopharmaceutical company based in the US, Ardelyx, unveiled their NHE3 Inhibitor drug called IBSRELA. IBSRELA serves as an innovative form of treatment for adult individuals suffering from irritable bowel syndrome accompanied by constipation (IBS-C). It operates by hindering the Sodium-Hydrogen Exchanger 3 (NHE3) within the tiny intestine and the colon. In vivo studies have demonstrated its capacity to lessen abdominal pain by reducing visceral hypersensitivity and enhancing intestinal permeability.
How Is the Visceral Pain Market Segmented?
The visceral pain market covered in this report is segmented -
1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn's, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs
3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report
Where Is the Visceral Pain Market Growth Most Prominent?
North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Visceral Pain Global Market Report?
- Market Size Analysis: Analyze the Visceral Pain Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Visceral Pain Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Visceral Pain Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Visceral Pain Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13950
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion: A Key Factor Shaping the Future of the Visceral Pain Market in 2025 here
News-ID: 3856353 • Views: …
More Releases from The Business Research Company
Increasing Cardiovascular Diseases Drives Market Growth Driver: A Major Catalyst …
What market dynamics are playing a key role in accelerating the growth of the hypercholesterolemia market?
The increasing incidence of cardiovascular diseases is expected to drive the growth of the hypercholesterolemia market. Cardiovascular diseases (CVDs) include a range of disorders that affect the heart and blood vessels. The rise in cardiovascular diseases is attributed to unhealthy diets, physical inactivity, obesity, chronic stress, aging populations, and the prevalence of conditions such as…
A Deep Dive into Granulomatosis With Polyangiitis Treatment Market 2025: Key Dri …
Which drivers are expected to have the greatest impact on the over the granulomatosis with polyangiitis treatment market's growth?
The growing prevalence of autoimmune diseases is expected to fuel the expansion of the granulomatosis with polyangiitis treatment market. Autoimmune diseases occur when the immune system mistakenly attacks healthy cells and tissues, leading to inflammation and organ damage. Factors like environmental triggers (e.g., infections, chemicals, or pollutants) and lifestyle changes are contributing…
Rising Prevalence Of Lifestyle-Related Diseases To Propel Growth In The Market D …
What industry-specific factors are fueling the growth of the erectile dysfunction market?
The rising prevalence of lifestyle-related diseases is expected to drive the erectile dysfunction (ED) market. Conditions such as obesity, poor diet, sedentary lifestyles, and excessive alcohol consumption contribute to the rise in lifestyle-related diseases, which often lead to erectile dysfunction. ED is often an early indicator of underlying cardiovascular diseases, diabetes, or other health issues, making its treatment crucial…
Rising Alzheimer's Cases Propel Growth Of The Market Driver: Leading Transformat …
What combination of drivers is leading to accelerated growth in the donepezil market?
The increasing prevalence of Alzheimer's disease is expected to propel the growth of the donepezil market. Alzheimer's disease, a progressive neurological disorder, is becoming more prevalent due to factors like an aging population, lifestyle changes, and genetic predispositions. Donepezil is a well-known treatment that helps manage symptoms of Alzheimer's by improving cognitive function. As the number of individuals…
More Releases for Visceral
Visceral Pain associated with GI disorders Market to Witness Growth by 2032, Est …
DelveInsight's "Visceral Pain associated with GI disorders Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Visceral Pain associated with GI disorders, historical and forecasted epidemiology as well as the Visceral Pain associated with GI disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Visceral Pain associated with GI disorders market report provides current treatment practices, emerging drugs,…
Visceral Pain Treatment Market Aims to Expand at Double-Digit Growth Rate | Grun …
This Visceral Pain Treatment market report's primary elements include the global marketplace, high-potential opportunities, and ongoing development visions. It also gives statistics on a variation of topics to prevent industry participants stay inundated in a fast-paced worldwide market.
Get Sample Copy of Visceral Pain Treatment Market Report at:
https://www.globalmarketmonitor.com/request.php?type=1&rid=727782
This global Visceral Pain Treatment market report considers their revenue, production and capacity, manufacturing sites, ex-factory price and market share in the market. Additionally,…
Visceral Pain Market Industry Report 2020-2027 Top Players, Demand, New Innovati …
Latest released the research study on Global Visceral Pain Market, offers a detailed overview of the factors influencing the global business scope. Visceral Pain Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Visceral Pain The report represents a basic overview of the…
Visceral Pain Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results
Visceral pain is the most frequent form of clinically relevant pain for those patients seek medical attention. There are several causes of visceral pain. Nociceptive pain causes direct injury of an internal organs, that leads to cardiac ischemic, and peptic ulcer.
Download the sample report @ https://www.pharmaproff.com/request-sample/1108
Medications for visceral pain treatment includes analgesics such as nonsteroidal anti-inflammatory drugs, paracetamol and serotonergic compounds. Opioids are also used for the treatment of…
Visceral Pain Market Potential Growth and Market Key Players 2018-2023
Visceral Pain Market Forecast – 2023 research and analysis focus on rising market drifts to assist businesses find market opportunities and develop effective ways to optimise their market positions. Report contains complete coverage, intensive analysis, and actionable market insights to spot opportunities in existing and potential markets. Report also contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Visceral Pain market…
Visceral Pain - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Visceral Pain - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Visceral Pain Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Visceral Pain - Pipeline Review, H1 2018, provides an overview of the Visceral Pain (Central Nervous System) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581022
Visceral pain is a type…
